Valuation (88%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1.58 | N/A |
| PEG Ratio (TTM) | 0.04 | N/A |
| P/S Ratio (TTM) | 0.59 | N/A |
| P/B Ratio (TTM) | 11.41 | N/A |
| P/FCF Ratio (TTM) | 5.79 | N/A |
| Price to 5YR AVG Earnings Ratio | 2.87 | N/A |
| Price to 5YR AVG FCF Ratio | 4.26 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.53% | N/A |
| ROE (TTM) | 19.32% | N/A |
| Net Profit Margin (TTM) | 5.65% | N/A |
| ROIC 5YR AVG | 5.32% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 48.31% | 653.78% | 417.72% |
| Revenue | 32.50% | 5.09% | -1.93% |
| Net Income | 47.20% | 639.87% | 408.94% |
| Cash Flow | 266.56% | -16.51% | -14.15% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.06 | N/A |
| Quick Ratio (TTM) | 3.06 | N/A |
| D/E Ratio (TTM) | 35.76 | N/A |
| Interest Coverage (TTM) | 17.02 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.28 | N/A |
| LTL to 5YR AVG FCF | 2.07 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.66% | N/A |